Clinical trial

Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder

NCT00810069

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-11-01

PhasePHASE4

Study timeline

Study start (unknown)2008-11-01Date precision: month

Registry last updated2011-06-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

Duloxetine HydrochlorideDRUG · verified · RxNorm: duloxetine hydrochloride

EscitalopramDRUG · verified · RxNorm: escitalopram

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

MadridSpain1 BarcelonaSpain1 MilanItaly1 BudapestHungary1 SevilleSpain1 MarseilleFrance1 MontpellierFrance1 BucharestRomania1 StockholmSweden1 AnkaraTurkey (Türkiye)1 AthensGreece1 RennesFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00810069 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.